Concepedia

David Stroncek

DS

10

Publications

619

Citations

10

H-Index

2004

Active since

Affiliations

National Institutes of Health(Current)

National Institutes of Health Clinical Center

Center for Cancer Research

National Cancer Institute

Stanford University

David Stroncek is an author at National Institutes of Health specializing in autoimmunity, autoimmune disease, and tumor immunity.

Top concepts

Publications per year

2004–2023

10

Publications

10

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer

Hye Won Chung, Sang‐Guk Lee, Heejung Kim et al. · Journal of Translational Medicine · 2009 · 120 citations · Full text

Long-Term Outcomes Following CD19 CAR T Cell Therapy for B-ALL Are Superior in Patients Receiving a Fludarabine/Cyclophosphamide Preparative Regimen and Post-CAR Hematopoietic Stem Cell Transplantation

Daniel W. Lee, Maryalice Stetler‐Stevenson, Constance M. Yuan et al. · Blood · 2016 · 118 citations

Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy

Sabina Kaczanowska, Tara Murty, Ahmad Alimadadi et al. · Cancer Cell · 2023 · 91 citations · Full text

, , +10

Developing Cellular Therapies for Retinal Degenerative Diseases

Kapil Bharti, Mahendra S. Rao, Sara Chandros Hull et al. · Investigative Ophthalmology & Visual Science · 2014 · 74 citations

Minimal Residual Disease Negative Complete Remissions Following Anti-CD22 Chimeric Antigen Receptor (CAR) in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

Nirali N. Shah, Maryalice Stetler‐Stevenson, Constance M. Yuan et al. · Blood · 2016 · 51 citations

Rows per page

1–5 of 10